3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
108
Carcinoma, Non-Small-Cell Lung
97
Multiple Myeloma
81
Prostatic Neoplasms
74
Colorectal Neoplasms
60
Neoplasms
58
Leukemia, Myeloid, Acute
56
Lymphoma
48
Squamous Cell Carcinoma of Head and Neck
43
Melanoma
40
Lung Neoplasms
40
Ovarian Neoplasms
38
Neoplasm Metastasis
37
Pancreatic Neoplasms
36
Lymphoma, Non-Hodgkin
36
Carcinoma, Hepatocellular
34
Lymphoma, Large B-Cell, Diffuse
33
Head and Neck Neoplasms
32
Sarcoma
31
Carcinoma, Renal Cell
31
Urinary Bladder Neoplasms
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Endometrial Neoplasms
29
Leukemia, Lymphocytic, Chronic, B-Cell
28
Hodgkin Disease
28
Triple Negative Breast Neoplasms
27
Myelodysplastic Syndromes
27
Hematologic Neoplasms
26
Recurrence
25
Glioma
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase 2
×
Aumolertinib
×
30 days
×
Clear all
No trials found.